Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a randomized double-blind placebo-controlled study of RIST4721 in palmoplantar pustulosis
2018-004176-35Phase 2Completed
- Sponsor
- Aristea Therapeutics
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Palmoplantar Pustular Psoriasis (PPPP) comparing RIST4721 with Placebo (2 arms). Started Jan 2019; status: completed.
02
Drugs
vimnerixin
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on 2018-004176-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004176-35.